Delivery Order SPE2DR25D3301-SPE2DR26F20TZ
- Not listed
- The Defense Logistics Agency awarded a $19,111.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 14, 2026, for the supply of Varivax vaccine with diluents. This non-competitive delivery order, with an ultimate completion date of February 5, 2026, represents a task order issued under a larger contract vehicle supporting federal medical procurement. The work will be performed at Amerisourcebergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,548.22 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 3, 2026. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $6,370.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by February 5, 2026. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a task order against AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,012.19 for Varivax vaccine with diluents, with an ultimate completion date of January 9, 2026. This competitive award, issued on December 17, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $6,708.60 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 29, 2026. The awardee will perform at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's...
- The Defense Logistics Agency awarded a $11,001.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Varivax vaccine with diluents, with an ultimate completion date of January 29, 2026. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,367.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of January 29, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $55,008.50 by the Defense Logistics Agency (DLA) on January 6, 2026, for the supply of Varivax vaccine with diluents. The order will be completed by January 28, 2026, with performance at the company's headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and falls under Amerisourcebergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,001.70 for Varivax vaccine with diluents, with an ultimate completion date of January 23, 2026. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20TZDelivery Order
The Defense Logistics Agency awarded a $2,548.22 delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 14, 2026, for the supply of Varivax vaccine with diluents. This firm fixed-price contract, which is not set-aside and has an ultimate completion date of February 5, 2026, represents a task order under a larger vehicle supporting the agency's medical supply chain operations. The performance location is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office and serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. This delivery order operates under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which enables the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. The contract award reflects Amerisourcebergen's continued role as a primary pharmaceutical vendor for federal government agencies, competing on a full and open basis to fulfill essential medical commodity requirements across the Department of Defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/13/26 |